INNOSPEC INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.8B | $1.8B | $1.9B | $2.0B | $1.5B |
| Cost of revenue | $1.3B | $1.3B | $1.4B | $1.4B | $1.0B |
| Gross profit | $492.4M | $542.9M | $591.1M | $586.7M | $434.9M |
| Selling, general & administrative | $285.1M | $305.3M | $380.5M | $360.7M | $267.2M |
| Research and development | $51.0M | $56.5M | $49.0M | $38.7M | $37.4M |
| Operating expenses | $362.9M | $365.0M | $429.5M | $399.4M | $302.8M |
| Operating income | $129.5M | $177.9M | $161.6M | $187.3M | $132.1M |
| Pretax income | $138.1M | $41.2M | $174.4M | $184.6M | $134.4M |
| Income tax expense | $21.5M | $5.6M | $35.3M | $51.6M | $41.3M |
| Net income | $116.6M | $35.6M | $139.1M | $133.0M | $93.1M |
| Balance Sheet | |||||
| Cash and equivalents | $292.5M | $289.2M | $203.7M | $147.1M | $141.8M |
| Current assets | $1.0B | $956.6M | $885.7M | $872.6M | $728.1M |
| Total assets | $1.8B | $1.7B | $1.7B | $1.6B | $1.6B |
| Current liabilities | $360.1M | $371.4M | $371.5M | $405.8M | $336.6M |
| Total liabilities | $499.5M | $518.6M | $557.8M | $563.3M | $537.9M |
| Stockholders' equity | $1.3B | $1.2B | $1.1B | $1.0B | $1.0B |
| Cash Flow Statement | |||||
| Cash from operations | $138.3M | $184.5M | $207.3M | $81.7M | $93.2M |
| Depreciation and amortization | $43.6M | $43.5M | $39.3M | $40.1M | $42.7M |
| Stock-based compensation | $8.1M | $8.5M | $8.0M | $6.7M | $4.4M |
| Dividends paid | $42.4M | $38.8M | $35.1M | $31.7M | $28.8M |
| Share repurchases | $23.9M | $700,000 | $1.1M | $5.9M | $800,000 |
| Impairments | $22.9M | $0 | $0 | $0 | $0 |
Shares outstanding 24.6M · Free float 98.5%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.